Ie‐Ming Shih

Active 1993–2025

Also published as
Ie-Ming Shih · Ie Ming Shih · Ie−Ming Shih
223
Papers
44,294
Citations
111
h-index
207
i10-index

Citations

Citations per year for Ie‐Ming Shih1962: 1 citations1980: 1 citations1983: 1 citations1985: 1 citations1989: 1 citations1990: 2 citations1991: 1 citations1992: 1 citations1994: 6 citations1995: 3 citations1996: 3 citations1997: 5 citations1998: 17 citations1999: 16 citations2000: 34 citations2001: 51 citations2002: 85 citations2003: 97 citations2004: 160 citations2005: 153 citations2006: 141 citations2007: 193 citations2008: 204 citations2009: 256 citations2010: 323 citations2011: 455 citations2012: 513 citations2013: 575 citations2014: 472 citations2015: 490 citations2016: 508 citations2017: 448 citations2018: 489 citations2019: 1,531 citations2020: 1,622 citations2021: 1,512 citations2022: 1,213 citations2023: 944 citations2024: 1,431 citations2025: 690 citations2026: 14 citations1963–1979: no citations, so these years are not shown1981–1982: no citations, so these years are not shown1984: no citations, so this year is not shown1986–1988: no citations, so these years are not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,206 citing papers, 28.8% of this breakdownChina: 1,853 citing papers, 12.7% of this breakdownUnited Kingdom: 920 citing papers, 6.3% of this breakdownGermany: 679 citing papers, 4.6% of this breakdownCanada: 665 citing papers, 4.5% of this breakdownItaly: 602 citing papers, 4.1% of this breakdownJapan: 541 citing papers, 3.7% of this breakdownAustralia: 406 citing papers, 2.8% of this breakdownFrance: 393 citing papers, 2.7% of this breakdownNetherlands: 345 citing papers, 2.4% of this breakdownSpain: 324 citing papers, 2.2% of this breakdownSouth Korea: 282 citing papers, 1.9% of this breakdown
0%28.8%Other 23.3%

Fields

  • Medicine48.7%
  • Biochemistry, Genetics and Molecular Biology40.1%
  • Immunology and Microbiology3.9%
  • Chemistry2.4%
  • Agricultural and Biological Sciences1.2%
  • Materials Science0.8%
  • Other2.9%

Topics

  • Ovarian cancer diagnosis and treatment6.5%
  • Cancer Genomics and Diagnostics3.6%
  • Endometrial and Cervical Cancer Treatments2.7%
  • Epigenetics and DNA Methylation2.5%
  • Chromatin Remodeling and Cancer2.3%
  • Endometriosis Research and Treatment2.1%
  • Other80.3%

Coauthors

All papers

Open in search
  1. Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tao Liu, Bing Zhang, Akhilesh Pandey, Amanda G. Paulovich, Andrew N. Hoofnagle, D.R. Mani, Daniel W. Chan, David F. Ransohoff, David Fenyö, David L. Tabb, Douglas A. Levine, Emily S. Boja, Eric Kuhn, Forest M. White, Gordon A. Whiteley, Heng Zhu, Hui Zhang, Ie‐Ming Shih, Jasmin Bavarva, Jeffrey R. Whiteaker, Karen A. Ketchum, Karl R. Clauser, Kelly V. Ruggles, Kimberly Elburn, Linda I. Hannick, Mark A. Watson, Mauricio Oberti, Mehdi Mesri, Melinda E. Sanders, Melissa Borucki, Michael A. Gillette, M Snyder, Nathan Edwards, Negin Vatanian, Paul A. Rudnick, Peter B. McGarvey, Philip Mertins, R. Reid Townsend, Ratna R. Thangudu, Robert Rivers, Samuel Payne, Sherri R. Davies, Shuang Cai, Stephen E. Stein, Steven A. Carr, Steven J. Skates, Subha Madhavan, Tara Hiltke, Xian Chen, Yingming Zhao, Yue Wang, Zhen Zhang - Cell 2019 cited by 862

  2. Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tara Hiltke, Emily S. Boja, Mehdi Mesri, Ana I. Robles, Henry Rodriguez, Thomas F. Westbrook, Li Ding, Gad Getz, Karl R. Clauser, David Fenyö, Kelly V. Ruggles, Bing Zhang, D.R. Mani, Steven A. Carr, Matthew J. Ellis, Michael A. Gillette, Shayan C. Avanessian, Shuang Cai, Daniel Chan, Xian Chen, Nathan Edwards, Andrew N. Hoofnagle, M. Harry Kane, Karen A. Ketchum, Eric Kuhn, Douglas A. Levine, Shunqiang Li, D.C. Liebler, Tao Liu, Jingqin Luo, Subha Madhavan, Christopher G. Maher, Jason McDermott, Peter B. McGarvey, Mauricio Oberti, Akhilesh Pandey, Samuel Payne, David F. Ransohoff, Robert Rivers, Karin Rodland, Paul A. Rudnick, Melinda E. Sanders, Kenna M. Shaw, Ie‐Ming Shih, Robbert J.C. Slebos, Richard Smith, M Snyder, Stephen E. Stein, David L. Tabb, Ratna R. Thangudu, Stefani N. Thomas, Yue Wang, Forest M. White, Jeffrey R. Whiteaker, Gordon A. Whiteley, Hui Zhang, Zhen Zhang, Yingming Zhao, Heng Zhu, Lisa J. Zimmerman - Cell 2020 cited by 575

  3. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vineet Bafna, Yue Wang, Henry Rodriguez, Emily S. Boja, Tara Hiltke, Robert Rivers, Lori J. Sokoll, Heng Zhu, Ie‐Ming Shih, Leslie Cope, Akhilesh Pandey, Bing Zhang, M Snyder, Douglas A. Levine, Richard Smith, Daniel W. Chan, Karin Rodland, Steven A. Carr, Michael A. Gillette, Karl R. Klauser, Eric Kuhn, D.R. Mani, Philipp Mertins, Karen A. Ketchum, Ratna R. Thangudu, Shuang Cai, Mauricio Oberti, Amanda G. Paulovich, Jeffrey R. Whiteaker, Nathan Edwards, Peter B. McGarvey, Subha Madhavan, Pei Wang, Daniel W. Chan, Akhilesh Pandey, Ie‐Ming Shih, Hui Zhang, Zhen Zhang, Heng Zhu, Leslie Cope, Gordon A. Whiteley, Steven J. Skates, Forest M. White, Douglas A. Levine, Emily S. Boja, Christopher R. Kinsinger, Tara Hiltke, Mehdi Mesri, Robert Rivers, Henry Rodriguez, Kenna M. Shaw, Stephen E. Stein, David Fenyö, Tao Liu, Jason McDermott, Samuel Payne, Karin Rodland, Richard Smith, Paul A. Rudnick, M Snyder, Yingming Zhao, Xian Chen, David F. Ransohoff, Andrew N. Hoofnagle, D.C. Liebler, Melinda E. Sanders, Zhiao Shi, Robbert J.C. Slebos, David L. Tabb, Bing Zhang and 10 more - Cell 2016 cited by 1,126

  4. ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dianne Miller, Steven J.M. Jones, Richard A. Moore, Gregg B. Morin, Arusha Oloumi, Niki Boyd, Samuel Aparício, Ie Ming Shih, Anne‐Marie Mes‐Masson, David D.L. Bowtell, Martin Hirst, C. Blake Gilks, Marco A. Marra, David G. Huntsman - New England Journal of Medicine 2010 cited by 1,702

  5. The Origin and Pathogenesis of Endometriosis

    Authors: , , - Annual Review of Pathology Mechanisms of Disease 2019 cited by 460

  6. High grade serous ovarian carcinomas originate in the fallopian tube

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2017 cited by 767

  7. The Dualistic Model of Ovarian Carcinogenesis

    Authors: , - American Journal Of Pathology 2016 cited by 922

  8. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers

    Authors: , , , , , , , , , , , - Nature Medicine 2015 cited by 680

  9. Cancer-Associated Mutations in Endometriosis without Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cristian Tomasetti, Niki Boyd, Kenneth W. Kinzler, C. Blake Gilks, Luis A. Díaz, Tian‐Li Wang, Bert Vogelstein, Paul J. Yong, David G. Huntsman, Ie‐Ming Shih - New England Journal of Medicine 2017 cited by 623

  10. Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

    Authors: , , , , , , , , , , , , - Science 2010 cited by 1,226

  11. The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

    Authors: , - The American Journal of Surgical Pathology 2010 cited by 1,839

  12. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ming Zhang, Roger E. McLendon, Darell D. Bigner, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Hai Yan - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 1,375

  13. ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors

    Authors: , , , , , , , , , , , , , , , - Cancer Discovery 2015 cited by 531

  14. The Origin of Ovarian Cancer Species and Precancerous Landscape

    Authors: , , - American Journal Of Pathology 2020 cited by 255

  15. Ovarian Cancer

    Authors: , - Annual Review of Pathology Mechanisms of Disease 2008 cited by 695

  16. Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden

    Authors: , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 288

  17. C ombination A TR (ceralasertib) and P A R P (olaparib) I nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2023 cited by 77

  18. Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance

    Authors: , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2023 cited by 81

  19. Long Interspersed Element-1 Protein Expression Is a Hallmark of Many Human Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal Of Pathology 2014 cited by 371

  20. Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Forest M. White, Gordon A. Whiteley, Heng Zhu, Ie‐Ming Shih, Jasmin Bavarva, Jason McDermott, Jeffrey R. Whiteaker, Karen A. Ketchum, Karl R. Clauser, Kelly V. Ruggles, Kimberly Elburn, Li Ding, Linda I. Hannick, Lisa J. Zimmerman, Mark A. Watson, Mathangi Thiagarajan, Matthew J. Ellis, Mauricio Oberti, Mehdi Mesri, Melinda E. Sanders, Melissa Borucki, Michael A. Gillette, M Snyder, Nathan Edwards, Negin Vatanian, Paul A. Rudnick, Peter B. McGarvey, Philip Mertins, R. Reid Townsend, Ratna R. Thangudu, Richard Smith, Robert Rivers, Robert J.C. Slebos, Samuel Payne, Sherri R. Davies, Shuang Cai, Stephen E. Stein, Steven A. Carr, Steven J. Skates, Subha Madhavan, Tao Liu, Xian Chen, Yingming Zhao, Yue Wang, Zhiao Shi - Cell Reports 2020 cited by 155

  21. Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review

    Authors: , , , , , - Cancers 2022 cited by 148

  22. Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - American Journal Of Pathology 2011 cited by 520

  23. Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Gynecologic Oncology 2021 cited by 117

  24. PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Immunology Research 2019 cited by 151